Theoretical and practical implications of a controlled trial of an alpha 2-adrenoceptor antagonist in the treatment of depression.
Montgomery
S A
SA
St. Mary's Hospital Medical School, Academic Department of Psychiatry, London, England.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D012107:Research Design
D000317:Adrenergic alpha-Antagonists